AGAliaa El Gendy

Aliaa El Gendy

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Aliaa El Gendy has a total of 57 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Evaluation of the efficiency of low-power laser shower in management of knee osteoarthritis

    by Aliaa El Gendy, Amira Medhat, Emad N. Zikri, Khaled G. Abdel-Wahhab, Fatma A. Ibrahim, Heba F. Shafei, Suzanne Fouad


  • Evaluation of the apiacupuncture against the damages and erythrocyte osmotic fragility induced by oxidative stress in Egyptian patients with chronic neck pain

    by Ahmed G. Hegazi, Fatma A. A. Ibrahim, Mona M.F. Ganem, Eman H. Abdel-Rahman, Samir W. Aziz, Amira Medhat, Rasha Monir, Aliaa El Gendy

    Many people suffer from neck pain due to a sedentary lifestyle. It has become imperative to study dealing with neck pain in Oriental medicine. Thirty female patients diagnosed with chronic neck pain were subjected to this study & thirty healthy control. The mean of the Visual analog scale (VAS) and of the Neck Disability Index Questioner (NDIQ) were significantly decreased (P< 0.05) after bee venom therapy. Also a significant decrease in Oxidative stress markers after bee venom administration, where malondialdehyde (MDA) & Glutathione S-transferases (GST) activities were decreased after treatment. On the other hand, catalase activities after bee venom were increased with a significant difference (P<0.05). Moreover, bee venom acupuncture diminished the elevated average osmotic fragility and decreased the elevated rate of haemolysis. Results suggested that bee venom could be a supportive antioxidant that plays an important role in damage control caused by oxidative stress. It can be concluded that Bee venom pharm-acupuncture has been reported to be effective in treating and dominating neck pain.The aim of this study was to evaluate the role of bee venom acupuncture in chronic neck pain patients, concerning pain intensity and supported lifestyle quality with controlling oxidative damage.


  • Clinical evaluation of selected homeopathic therapies for alleviating the symptoms of menopausal cases in women

    by Rasha Monir, Heba F. Shafei, Suzanne Fouad, Khaled G. Abdel-Wahhab, Aliaa Elgendy


  • Open Access

    The association between vitamin D levels and oxidative stress markers in Egyptian Behcet’s disease patients

    by Heba S. Omar, Fatma Mohamed Taha, Suzanne Fouad, Fatma A. Ibrahim, Aliaa El Gendy, Iman H. Bassyouni, Reem El-Shazly

    Background: Oxidative stress is postulated to have a major role in the pathophysiology of Bechet’s Disease (BD). Growing evidence suggests that vitamin D has important roles in enhancing the expression of anti-inflammatory cytokines as well as certain antioxidants. However, there is little evidence currently about the antioxidant properties of vitamin D in BD. Objective: To study the relationship between vitamin D levels and the oxidative stress markers in patients with BD in addition to its association with disease activity and severity. Methods: Sixty BD patients (45 males, 15 females; mean age: 34.2 ± 9.6 years) were enrolled in this study and compared to a sex and age matched control group. Plasma 25-Hydroxy vitamin D (25-OH-D) was measured using Human (25-OH-D) ELISA assay. Plasma malondialdehyde (MDA), nitric oxide (NO), reduced glutathione (GSH), superoxide dismutase (SOD) activity, catalase (CAT) activity and total antioxidant capacity (TAC) were determined by spectrophotometric methods in both groups. Plasma calcium (Ca) was measured by ELISA assay. Results: When compared to controls vitamin D, GSH, CAT activity, TAC and Ca were significantly lower in BD patients, while MDA and NO levels were significantly increased in BD patients. Our Results Found that vitamin D was inversely correlated to BD current Activity form (BDCAF), disease severity score, ESR, CRP, MDA and NO, while vitamin D was significantly positively correlated to GSH, SOD, TAC and Ca. Conclusion: Our study confirms that a lower level of vitamin D is associated with the oxidative stress state in BD patients as detected by MDA and NO elevation as well as decreased GSH, SOD activity, CAT activity and TAC. Hence, Vitamin D fortified foods and beverages or supplementation may improve disease severity and oxidative stress in BD patients.


  • Open Access

    Effectiveness of low-power laser therapy in improvement of the peripheral neuropathy induced by xenobiotics in rats

    by Fathia Abd Elwahid Mannaa, Khaled Gamal El-Deen Abdel-Wahhab, Eitedal Mahmoud Daoud, Aliaa Abdel Rahman El Gendy, Maha Mohamed Saber, Nevein Naim Fadl


  • Nutritional Supplement Prepared from Whole Meal Wheat Flour, Soya Bean Flour, Flaxseed and Anise Seeds for Alleviating the Menopausal Symptoms

    by Suzanne Fouad, Salwa Mostafa El, Maha Abdel-Moat, Nihad Hassan Ahm, Ahmed Mohamed Sa, Aliaa El Gendy, Hend Abass Essa, Salwa Tawfic Tap

    Nutritional Supplement Prepared from Whole Meal Wheat Flour, Soya Bean Flour, Flaxseed and Anise Seeds for Alleviating the Menopausal Symptoms


  • Efficiencies of Low-Level Laser Therapy (LLLT) and Gabapentin in the Management of Peripheral Neuropathy: Diabetic Neuropathy

    by Khaled G. Abdel-Wahhab, Eitedal M. Daoud, Aliaa El Gendy, Hagar H. Mourad, Fathia A. Mannaa, Maha M. Saber

    Diabetic neuropathy (DN) is the highly occurred complication of diabetes mellitus; it has been defined as an event of peripheral nerve dysfunction characterized by pain, allodynia, hyperalgesia, and paraesthesia. The current study was conducted to evaluate the efficacy of low-level laser therapy (LLLT) in the management of neuropathy in diabetic rats. The used animals were divided into the following groups: negative control, streptozotocin-induced diabetic rats, and diabetic rats with peripheral neuropathy (DNP) and DNP treated with gabapentin or with LLLT. Behavioral tests were carried out through hotplate test for the determination of pain sensations and the Morris water maze test for spatial reference memory evaluation. Blood samples were collected at the end of treatment for biochemical determinations. In the current study, the latency of hind-paw lick decreased significantly when DNP are treated with gabapentin or LLLT. The Morris water maze test showed that LLLT treatment improved memory that deteriorated in DNP more than gabapentin do. The results of the biochemical study revealed that LLLT could not affect the level of beta-endorphin that decreased in DNP but significantly decreased S100B that rose in DNP. PGE2 and cytokines IL-1β, IL-10, and TNF-α showed significant increase in DNP compared with control group. The gabapentin administration or LLLT application significantly reversed the levels of the mentioned markers towards the normal values of the controls. Levels of serum MDA and nitric oxide increased significantly in the DNP but rGSH showed significant decrease. These markers were improved significantly when the DNP were treated with gabapentin or LLLT. The treatment with gabapentin or LLLT significantly decreased the raised level in total cholesterol in DNP but could not decrease the elevated level of triglycerides, while LDL cholesterol decreased significantly in DNP treated with gabapentin but not affected by LLLT. Values of serum alanine aminotransferase (ALAT), aspartate aminotransferase (ASAT), urea, and creatinine increased significantly in the DPN and diabetic rats without peripheral neuropathy (PN) compared with control group. The treatment of DNP with gabapentin induced significant increases in ALAT and ASAT activities but LLLT treatment induced significant decreases in ALAT and ASAT activities as compared with DNP group. Neither gabapentin nor LLLT could improve the elevated levels of serum urea and creatinine in the DNP. It could be concluded that LLLT is more safe and effective than gabapentin in the management of neuropathy in diabetic rats.


  • Innovative Food Supplement of Functional Seeds Mixture Improved Bone Mineral Density in Menopausal Egyptian Women

    by Moetazza M. Alshafei, Seham S. Kassem, Manal M. Ramadan, Emtenan M. Hanafi, Maha M. Saber, Lobna M. Saber, Aliaa Elgendy


  • Evaluation of serum beta-endorphin and substance P in knee osteoarthritis patients treated by laser acupuncture

    by Nagwa Mohammed, Hemat Allam, Eman Elghoroury, Emad N. Zikri, Ghada A. Helmy, Aliaa Elgendy

    Background: Laser acupuncture is one of the complementary modalities used for treating osteoarthritis. The study was performed to evaluate the effectiveness of laser acupuncture in the treatment of grade 2 knee osteoarthritis. Patients and methods: Forty patients having bilateral knee osteoarthritis were divided into two groups (20 patients in each group). The patients of the first group were subjected to 12 laser sessions at the following acupoints (St 35, St36, Sp9, Sp10 and Gb 34). During each session, laser of 90 mw was directed to each acupoint for 1 min giving energy of 5.4 joules. Energy of 21.6 joules was directed to ashi points. The laser had a wavelength of 808 nm, beam diameter 2 mm and was applied with a continuous wave. The cases of the second group were used as controls. Each patient is exposed to sham laser (laser probe is directed to the same acupoints while the device is off). Results: The 20 patients receiving laser showed significant improvement in pain on (VAS), increase in serum beta-endorphin and a decrease in substance P more than those exposed to sham laser. Conclusions: Laser acupuncture is a safe and cheap tool for management of grade 2 knee osteoarthritis.


  • Growth Differentiation Factor-15 (GDF-15) Level and Relation to Clinical Manifestations in Egyptian Systemic Sclerosis patients: Preliminary Data

    by Sherif M. Gamal, Fatema T. Elgengehy, Asmaa Kamal, Samah A. El Bakry, Elham Shabaan, Aliaa Elgendy, Iman H. Bassyouni

    This study aims to assess Growth differentiation factor-15 (GDF-15) level in Scleroderma patients and its relation to disease manifestations. This study included 55 scleroderma patients and 40 age and sex matched healthy volunteers. All patients were subjected to full history taking, thorough clinical examination, and laboratory investigations. GDF-15 serum levels were analyzed in patients and controls using human GDF-15 immunoassay Quantikine ELISA kit. The GDF-15 serum level was significantly higher in Systemic sclerosis (SSc) patients in comparison to healthy control individuals, p-value = 0.004. In addition, the GDF-15 serum levels increased in a significant way in patients with diffuse SSc than those with limited SSc, p = 0.026. Also, we had discovered a significant positive correlation between serum GDF-15 levels and the modified Rodnan score of the SSc patients, r = 0.442, p = 0.001 and a significant association was found between high GDF-15 level and SSc patients with interstitial pulmonary fibrosis (IPF) as compared to healthy controls (p = 0.002). However, no significant difference was found between SSc patients without IPF and healthy subjects regarding GDF-15 level (p = 0.106). GDF-15 serum levels were elevated in patients with SSc and correlated with the extent of skin fibrosis, and it was found to be higher in SSc patients with IPF. Such results may suggest a pivotal role of GDF-15 in fibrotic changes in SSc, and GDF-15 could be a treatment target in SSc patients in future.